Hartford Healthcare HLS Fund Class IB (HBGHX) is a Health fund with $350.11 Million in assets. The fund allocates 44.71% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Eli Lilly Co at 12.16% of total assets. This is followed by UnitedHealth Group Inc (5.96%) and Merck Co Inc (4.19%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Eli Lilly Co | 12.16% | - | - |
| UnitedHealth Group Inc | 5.96% | - | - |
| Merck Co Inc | 4.19% | - | - |
| Danaher Corp | 3.57% | - | - |
| Boston Scientific Corp | 3.42% | - | - |
| Thermo Fisher Scientific Inc | 2.76% | - | - |
| Vertex Pharmaceuticals Inc | 3.07% | - | - |
| Stryker Corp | 2.43% | - | - |
| HCA Healthcare Inc | 2.40% | - | - |
| AbbVie Inc | 4.75% | - | - |
| Intuitive Surgical Inc | 3.23% | - | - |
| Johnson Johnson | 4.56% | - | - |
| Cencora Inc | 2.92% | - | - |
| Edwards Lifesciences Corp | 2.97% | - | - |